1887
Volume 2025, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Cerebral venous sinus thrombosis (CVST) is an uncommon yet critical complication, especially when arising from heparin-induced thrombocytopenia (HIT). In patients with preexisting conditions such as myasthenia gravis (MG), this correlation adds further complexity to clinical management and outcomes.

We report a unique case of CVST induced by HIT in a patient with an established diagnosis of MG. Following plasma exchange therapy, which included heparin administration, the patient developed symptoms indicative of CVST. Diagnostic imaging confirmed thrombosis in the cerebral venous sinuses. Management involved the immediate discontinuation of heparin and the initiation of fondaparinux, leading to effective anticoagulation and clinical improvement.

This case illustrates the rare intersection of CVST and HIT within the context of MG, underscoring the potential risks associated with heparin therapy in vulnerable patient populations. Early recognition of the signs is essential, as these conditions, in combination, demand prompt and specialized interventions to prevent serious complications.

The successful management of this complex case demonstrates the importance of heightened awareness and proactive strategies in patients with MG undergoing heparin therapy. This report advocates for careful monitoring and tailored treatment to mitigate risks in similarly complex clinical scenarios.

© 2025 AbuAlrob, Gumandera, Zammar, Al Qazakzeh, Alnakhala, Khalil, et al., licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.59
2025-06-09
2025-07-16
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/2/qmj.2025.59.html?itemId=/content/journals/10.5339/qmj.2025.59&mimeType=html&fmt=ahah

References

  1. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004; 35:(3)664–70. https://doi.org/10.1161/01.STR.0000117571.76197.26
     [Google Scholar]
  2. Einhäupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, et al.. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol. 2010; 17:(10)1229–35.
    [Google Scholar]
  3. Saposnik G, Barinagarrementeria F, Brown RD, Bushnell CD, Cucchiara B, Cushman M, et al.. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42:(4)1158–92.
    [Google Scholar]
  4. Dlamini N, Billinghurst L, Kirkham FJ. Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am. 2010; 21:(3)511–27.
    [Google Scholar]
  5. Coutinho JM, de Bruijn SF, deVeber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Stroke. 2012; 43:(4)e42. https://doi.org/10.1161/strokeaha.111.648162
     [Google Scholar]
  6. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001; 344:(17)1286–92. https://doi.org/10.1056/NEJM200104263441704
     [Google Scholar]
  7. Greinacher A. Heparin-induced thrombocytopenia. N Engl J Med. 2015; 373:(19)1883–4.
    [Google Scholar]
  8. Kelton JG, Arnold DM, Bates SM. Nonheparin anticoagulants for heparin-induced thrombocytopenia. N Engl J Med. 2013; 368:(8)737–44.
    [Google Scholar]
  9. Cohen M, Reichenbach Z, Baranov A, Eisenkraft A, Ben-David Y. Myasthenia gravis exacerbation and heparin-induced thrombocytopenia: a case report and review of the literature. Autoimmune Rev. 2024; 23:(2)102567.
    [Google Scholar]
  10. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005; 106:(8)2710–5.
    [Google Scholar]
  11. Warkentin TE. HIT paradigms and paradoxes. J Thromb Haemost. 2011; 9:(1)105–7.
    [Google Scholar]
  12. Cines DB, Rauova L, Arepally GM, Reilly MP, McKenzie SE, Sachais BS. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly. J Clin Apher. 2007; 22:(1)31–6.
    [Google Scholar]
  13. Linkins LA. Heparin induced thrombocytopenia. BMJ. 2015; 350::g7566. https://doi.org/10.1136/bmj.g7566
     [Google Scholar]
  14. Warkentin TE, Pai M, Linkins LA. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review. Blood. 2017; 130:(9)1104–13. https://doi.org/10.1182/blood-2017-04-778993
     [Google Scholar]
/content/journals/10.5339/qmj.2025.59
Loading
Cerebral venous sinus thrombosis as a complication of heparin-induced thrombocytopenia in myasthenia gravis: A rare and complex case
Qatar Medical Journal 2025, 59 (2025); https://doi.org/10.5339/qmj.2025.59
/content/journals/10.5339/qmj.2025.59
/content/journals/10.5339/qmj.2025.59
Loading

Data & Media loading...

  • Article Type: Case Report
Keyword(s): Cerebral venous sinus thrombosis and heparin included thrombocytopenia myasthenia gravis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error